NTRA

Natera, Inc. Common Stock

$394.75

Current Price

All

AI analysis

Read what the AI thinks of Natera, Inc. Common Stock in the app.

Analyses are generated by AI from public data and are not investment advice.

Get the app

Key figures

Dividend per share

—

Yield

—

EPS

-$1.37

P/E

—

Data as of Oct 8

Why it matters for the long term

Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Upcoming events

Quarterly earnings

After the close · Expected EPS: -$0.24

Nov 11

Posts

No posts about NTRA yet.

About Natera, Inc. Common Stock

Natera is a genetic testing company. It analyzes DNA from blood or tissue samples to answer questions like whether an unborn baby has a chromosomal condition, whether a couple carries genes that could cause disease in their children, whether a cancer patient's tumor DNA is still circulating after treatment, and whether a transplanted organ is being rejected by the body. It makes money by billing insurers, hospitals, and patients each time a doctor orders one of these lab tests.